186 related articles for article (PubMed ID: 33798546)
1. COR758, a negative allosteric modulator of GABA
Porcu A; Mostallino R; Serra V; Melis M; Sogos V; Beggiato S; Ferraro L; Manetti F; Gianibbi B; Bettler B; Corelli F; Mugnaini C; Castelli MP
Neuropharmacology; 2021 May; 189():108537. PubMed ID: 33798546
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
[TBL] [Abstract][Full Text] [Related]
4. KK-92A, a novel GABA
Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A
Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542
[TBL] [Abstract][Full Text] [Related]
5. The GABA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2017 Jan; 794():135-146. PubMed ID: 27876620
[TBL] [Abstract][Full Text] [Related]
6. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
7. GABA
de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER
Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
Urwyler S; Gjoni T; Koljatić J; Dupuis DS
Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
[TBL] [Abstract][Full Text] [Related]
10. Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors.
Urwyler S; Gjoni T; Kaupmann K; Pozza MF; Mosbacher J
Eur J Pharmacol; 2004 Jan; 483(2-3):147-53. PubMed ID: 14729102
[TBL] [Abstract][Full Text] [Related]
11. CGP7930 - An allosteric modulator of GABA
Hannan SB; Penzinger R; Mickute G; Smart TG
Neuropharmacology; 2023 Nov; 238():109644. PubMed ID: 37422181
[TBL] [Abstract][Full Text] [Related]
12. The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice.
Zemoura K; Ralvenius WT; Malherbe P; Benke D
Neuropharmacology; 2016 Sep; 108():172-8. PubMed ID: 27108932
[TBL] [Abstract][Full Text] [Related]
13. Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
Gjoni T; Urwyler S
Eur J Pharmacol; 2009 Jan; 603(1-3):37-41. PubMed ID: 19109945
[TBL] [Abstract][Full Text] [Related]
14. Effects of intraperitoneal administration of the GABAB receptor positive allosteric modulator 2,6-di tert-butyl-4-(2-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) on food intake in non-deprived rats.
Ebenezer IS
Eur J Pharmacol; 2012 Sep; 690(1-3):115-8. PubMed ID: 22652431
[TBL] [Abstract][Full Text] [Related]
15. Role of CA1 GABA
Ebrahimi-Ghiri M; Rostampour M; Jamshidi-Mehr M; Nasehi M; Zarrindast MR
Brain Res; 2018 Jan; 1678():164-173. PubMed ID: 29038006
[TBL] [Abstract][Full Text] [Related]
16. Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.
Gjoni T; Urwyler S
Neuropharmacology; 2008 Dec; 55(8):1293-9. PubMed ID: 18775443
[TBL] [Abstract][Full Text] [Related]
17. Structure optimization of positive allosteric modulators of GABA
Mugnaini C; Brizzi A; Mostallino R; Castelli MP; Corelli F
Bioorg Med Chem Lett; 2020 Sep; 30(18):127443. PubMed ID: 32730942
[TBL] [Abstract][Full Text] [Related]
18. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.
Urwyler S; Mosbacher J; Lingenhoehl K; Heid J; Hofstetter K; Froestl W; Bettler B; Kaupmann K
Mol Pharmacol; 2001 Nov; 60(5):963-71. PubMed ID: 11641424
[TBL] [Abstract][Full Text] [Related]
20. GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin.
Braun M; Wendt A; Buschard K; Salehi A; Sewing S; Gromada J; Rorsman P
J Physiol; 2004 Sep; 559(Pt 2):397-409. PubMed ID: 15235087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
